Levodopa challenge test: indications, protocol, and guide

J Neurol. 2021 Sep;268(9):3135-3143. doi: 10.1007/s00415-020-09810-7. Epub 2020 Apr 24.

Abstract

A drug challenge test in Parkinson's disease, such as the levodopa challenge test (LCT), is an easy and generally safe procedure, which has been used by clinicians for various indications. The results of the test have significant implications in the management of patients, from preoperative evaluation for deep brain stimulation to providing the basis for medication adjustments to address motor or non-motor fluctuations and dyskinesias. This paper reviews the different indications and protocols commonly used in an acute LCT. Potential complications of the procedure and an overview of levodopa responsiveness and unresponsiveness are also discussed.

Keywords: DBS screening; Levodopa challenge test; Levodopa responsiveness; Levodopa unresponsiveness; Parkinson's disease; Short-duration response.

Publication types

  • Review

MeSH terms

  • Antiparkinson Agents / adverse effects
  • Dyskinesias*
  • Humans
  • Levodopa / adverse effects
  • Parkinson Disease* / diagnosis
  • Parkinson Disease* / drug therapy

Substances

  • Antiparkinson Agents
  • Levodopa